Wells Fargo & Company Nant Health, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.38 - $0.61 $2 - $4	7 Added 3.63%	200 $0
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.78 $25,226 - $46,848	-60,062 Reduced 99.68%	193 $0
Q1 2022 May 16, 2022	SELL	$0.75 - $1.08 $75,039 - $108,056	-100,052 Reduced 62.41%	60,255 $45,000
Q4 2021 Feb 14, 2022	BUY	$0.94 - $1.85 $131,271 - $258,352	139,650 Added 676.04%	160,307 $169,000
Q3 2021 Nov 15, 2021	BUY	$1.61 - $2.41 $33,251 - $49,773	20,653 Added 516325.0%	20,657 $33,000
Q2 2021 Aug 16, 2021	SELL	$2.25 - $3.37 $61,976 - $92,826	-27,545 Reduced 99.99%	4 $0
Q1 2021 May 13, 2021	BUY	$3.0 - $5.1 $9,393 - $15,968	3,131 Added 12.82%	27,549 $88,000
Q4 2020 Feb 09, 2021	BUY	$1.96 - $3.56 $31,312 - $56,874	15,976 Added 189.24%	24,418 $79,000
Q3 2020 Nov 05, 2020	SELL	$2.1 - $5.99 $11,279 - $32,172	-5,371 Reduced 38.88%	8,442 $20,000
Q2 2020 Aug 13, 2020	BUY	$1.45 - $4.99 $19,814 - $68,188	13,665 Added 9233.11%	13,813 $63,000
Q1 2020 May 14, 2020	BUY	$0.97 - $2.27 $143 - $335	148 New	148 $0

Ticker NH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 115,550,000
Market Cap $48.5M
Description
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Ev...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.